LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 16703

Search options

  1. Article ; Online: K

    Mahato, Karuna / Bagdi, Prasanta Ray / Khan, Abu T

    Organic & biomolecular chemistry

    2017  Volume 15, Issue 26, Page(s) 5625–5634

    Abstract: ... nitrostyrenes in the presence of 10 mol% K ...

    Abstract An unprecedented and efficient method for the synthesis of useful thieno[2,3-b]thiochromen-4-one oximes is accomplished via a thio[3 + 2] cyclization reaction of 4-hydroxydithiocoumarins and trans-β-nitrostyrenes in the presence of 10 mol% K
    Language English
    Publishing date 2017-07-05
    Publishing country England
    Document type Journal Article
    ZDB-ID 2097583-1
    ISSN 1477-0539 ; 1477-0520
    ISSN (online) 1477-0539
    ISSN 1477-0520
    DOI 10.1039/c7ob01033h
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Phage K

    Lehman, Susan M / Kongari, Rohit / Glass, Adam M / Koert, Matthew / Ray, Melissa D / Plaut, Roger D / Stibitz, Scott

    Viruses

    2022  Volume 15, Issue 1

    Abstract: There is widespread interest in using obligately lytic bacteriophages ("phages") to treat human bacterial infections. ... ...

    Abstract There is widespread interest in using obligately lytic bacteriophages ("phages") to treat human bacterial infections. Among
    MeSH term(s) Animals ; Mice ; Humans ; Bacteriophages ; Methicillin-Resistant Staphylococcus aureus/genetics ; Staphylococcus aureus/genetics ; Temperature ; Anti-Bacterial Agents/pharmacology ; Staphylococcal Infections/therapy ; Staphylococcal Infections/microbiology
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2022-12-21
    Publishing country Switzerland
    Document type Journal Article ; Research Support, U.S. Gov't, P.H.S. ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v15010017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: A triple cysteine motif as major determinant of the modulation of neuronal K

    Ray, Sutirtha / Stampf, Jan-Luca / Kudlacek, Oliver / Yang, Jae-Won / Schicker, Klaus W / Graf, Yvonne / Losgott, Thomas / Boehm, Stefan / Salzer, Isabella

    British journal of pharmacology

    2024  

    Abstract: Background and purpose: The analgesic action of paracetamol involves K: Experimental approach ... site-directed mutagenesis, and mass spectrometry applied to recombinant K: Key results: Currents through the cardiac ... subtype K: Conclusion and implication: The paracetamol metabolite N-acetyl-p-benzo quinone imine (NAPQI ...

    Abstract Background and purpose: The analgesic action of paracetamol involves K
    Experimental approach: To address this question, we used a combination of perforated patch-clamp recordings, site-directed mutagenesis, and mass spectrometry applied to recombinant K
    Key results: Currents through the cardiac subtype K
    Conclusion and implication: The paracetamol metabolite N-acetyl-p-benzo quinone imine (NAPQI) modifies cysteine residues of K
    Language English
    Publishing date 2024-04-24
    Publishing country England
    Document type Journal Article
    ZDB-ID 80081-8
    ISSN 1476-5381 ; 0007-1188
    ISSN (online) 1476-5381
    ISSN 0007-1188
    DOI 10.1111/bph.16380
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model.

    Dutta, Debasmita / Ray, Priyanka / De, Archana / Ghosh, Arnab / Hazra, Raj Shankar / Ghosh, Pratyusha / Banerjee, Snigdha / Diaz, Francisco J / Upadhyay, Sunil P / Quadir, Mohiuddin / Banerjee, Sushanta K

    PloS one

    2024  Volume 19, Issue 4, Page(s) e0297749

    Abstract: ... of chemoresistance resulting from the addiction of mutant-K-RAS/AKT/ERK signaling-mediated desmoplastic barriers ... to GEM and denote a promising therapeutic target in PDAC with mutant K-RAS. ...

    Abstract Therapeutic options for managing Pancreatic ductal adenocarcinoma (PDAC), one of the deadliest types of aggressive malignancies, are limited and disappointing. Therefore, despite suboptimal clinical effects, gemcitabine (GEM) remains the first-line chemotherapeutic drug in the clinic for PDAC treatment. The therapeutic limitations of GEM are primarily due to poor bioavailability and the development of chemoresistance resulting from the addiction of mutant-K-RAS/AKT/ERK signaling-mediated desmoplastic barriers with a hypoxic microenvironment. Several new therapeutic approaches, including nanoparticle-assisted drug delivery, are being investigated by us and others. This study used pH-responsive nanoparticles encapsulated ERK inhibitor (SCH772984) and surface functionalized with tumor-penetrating peptide, iRGD, to target PDAC tumors. We used a small molecule, SCH772984, to target ERK1 and ERK2 in PDAC and other cancer cells. This nanocarrier efficiently released ERKi in hypoxic and low-pH environments. We also found that the free-GEM, which is functionally weak when combined with nanoencapsulated ERKi, led to significant synergistic treatment outcomes in vitro and in vivo. In particular, the combination approaches significantly enhanced the GEM effect in PDAC growth inhibition and prolonged survival of the animals in a genetically engineered KPC (LSL-KrasG12D/+/LSL-Trp53R172H/+/Pdx-1-Cre) pancreatic cancer mouse model, which is not observed in a single therapy. Mechanistically, we anticipate that the GEM efficacy was increased as ERKi blocks desmoplasia by impairing the production of desmoplastic regulatory factors in PDAC cells and KPC mouse tumors. Therefore, 2nd generation ERKi (SCH 772984)-iRGD-pHNPs are vital for the cellular response to GEM and denote a promising therapeutic target in PDAC with mutant K-RAS.
    MeSH term(s) Animals ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/pharmacology ; Deoxycytidine/administration & dosage ; Gemcitabine ; Pancreatic Neoplasms/drug therapy ; Pancreatic Neoplasms/pathology ; Pancreatic Neoplasms/genetics ; Pancreatic Neoplasms/metabolism ; Mice ; Humans ; Cell Line, Tumor ; Nanoparticles/chemistry ; Hydrogen-Ion Concentration ; Carcinoma, Pancreatic Ductal/drug therapy ; Carcinoma, Pancreatic Ductal/pathology ; Carcinoma, Pancreatic Ductal/genetics ; Carcinoma, Pancreatic Ductal/metabolism ; Proto-Oncogene Proteins p21(ras)/genetics ; Proto-Oncogene Proteins p21(ras)/metabolism ; Mutation ; Protein Kinase Inhibitors/pharmacology ; Disease Models, Animal ; Tumor Microenvironment/drug effects
    Chemical Substances Deoxycytidine (0W860991D6) ; Gemcitabine ; Proto-Oncogene Proteins p21(ras) (EC 3.6.5.2) ; Protein Kinase Inhibitors
    Language English
    Publishing date 2024-04-30
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0297749
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Lead-free (Ag,K)NbO

    Liu, Zhen / Lu, Teng / Xue, Fei / Nie, Hengchang / Withers, Ray / Studer, Andrew / Kremer, Felipe / Narayanan, Narendirakumar / Dong, Xianlin / Yu, Dehong / Chen, Longqing / Liu, Yun / Wang, Genshui

    Science advances

    2020  Volume 6, Issue 21, Page(s) eaba0367

    Abstract: Explosive energy conversion materials with extremely rapid response times have broad and growing applications in energy, medical, defense, and mining areas. Research into the underlying mechanisms and the search for new candidate materials in this field ... ...

    Abstract Explosive energy conversion materials with extremely rapid response times have broad and growing applications in energy, medical, defense, and mining areas. Research into the underlying mechanisms and the search for new candidate materials in this field are so limited that environment-unfriendly Pb(Zr,Ti)O
    Language English
    Publishing date 2020-05-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2810933-8
    ISSN 2375-2548 ; 2375-2548
    ISSN (online) 2375-2548
    ISSN 2375-2548
    DOI 10.1126/sciadv.aba0367
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first-line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysis.

    Corbaux, Pauline / You, Benoit / Glasspool, Rosalind M / Yanaihara, Nozomu / Tinker, Anna V / Lindemann, Kristina / Ray-Coquard, Isabelle L / Mirza, Mansoor R / Subtil, Fabien / Colomban, Olivier / Péron, Julien / Karamouza, Eleni / McNeish, Iain / Kelly, Caroline / Kagimura, Tatsuo / Welch, Stephen / Lewsley, Liz-Anne / Paoletti, Xavier / Cook, Adrian

    European journal of cancer (Oxford, England : 1990)

    2023  Volume 191, Page(s) 112966

    Abstract: ... constant K (KELIM) is an early indicator of the tumour intrinsic chemosensitivity. We assessed ...

    Abstract Background: In patients with advanced ovarian cancer, the modelled CA-125 ELIMination rate constant K (KELIM) is an early indicator of the tumour intrinsic chemosensitivity. We assessed the prognostic and surrogate values of KELIM with respect to those of surgery outcome (based on post-operative residual lesions) in the Gynaecologic Cancer Intergroup (GCIG) individual patient data meta-analysis MAOV (Meta-Analysis in OVarian cancer) built before the emergence of poly(ADP-ribose) polymerase (PARP) inhibitors.
    Methods: The dataset was split into learning and validation cohorts (ratio 1:2). The individual modelled KELIM values were estimated, standardised by the median value, then scored as unfavourable (<1.0) or favourable (≥1.0). Overall survival (OS) and progression-free survival (PFS) analyses were performed with a two-step meta-analytic approach and surrogacy through a two-level meta-analytic model.
    Results: KELIM was assessed in 5884 patients from eight first-line trials (learning, 1962; validation, 3922). A favourable KELIM score was significantly associated with longer OS (validation set, median, 78.8 versus 28.4 months, hazard-ratios [HR] 0.46, 95% confidence interval [CI], 0.41-0.50, C-index 0.68), and longer PFS (validation set, median 30.5 versus 9.8 months, HR 0.49, 95% CI, 0.45-0.54, C-index 0.68), as were International Federation of Gynaecology and Obstetrics (FIGO) stage and debulking surgery outcome. Three prognostic groups were identified based on the surgery outcome and KELIM score, with large differences in OS (105.1, ∼45.0, and 22.1 months) and PFS (58.1, ∼15.0, and 8.0 months). Surrogacy for OS and for PFS was not established.
    Conclusion: KELIM is an independent prognostic biomarker for survival, complementary to surgery outcome, representing a new determinant of first-line treatment success.
    MeSH term(s) Humans ; Female ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; CA-125 Antigen ; Disease-Free Survival ; Antineoplastic Agents/therapeutic use ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/surgery
    Chemical Substances Poly(ADP-ribose) Polymerase Inhibitors ; CA-125 Antigen ; Antineoplastic Agents
    Language English
    Publishing date 2023-07-04
    Publishing country England
    Document type Meta-Analysis ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 82061-1
    ISSN 1879-0852 ; 0277-5379 ; 0959-8049 ; 0964-1947
    ISSN (online) 1879-0852
    ISSN 0277-5379 ; 0959-8049 ; 0964-1947
    DOI 10.1016/j.ejca.2023.112966
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Beam-Energy Dependence of Directed Flow of Λ, Λ[over ¯], K^{±}, K_{s}^{0}, and ϕ in Au+Au Collisions.

    Adamczyk, L / Adams, J R / Adkins, J K / Agakishiev, G / Aggarwal, M M / Ahammed, Z / Ajitanand, N N / Alekseev, I / Anderson, D M / Aoyama, R / Aparin, A / Arkhipkin, D / Aschenauer, E C / Ashraf, M U / Attri, A / Averichev, G S / Bai, X / Bairathi, V / Barish, K /
    Behera, A / Bellwied, R / Bhasin, A / Bhati, A K / Bhattarai, P / Bielcik, J / Bielcikova, J / Bland, L C / Bordyuzhin, I G / Bouchet, J / Brandenburg, J D / Brandin, A V / Brown, D / Bunzarov, I / Butterworth, J / Caines, H / Calderón de la Barca Sánchez, M / Campbell, J M / Cebra, D / Chakaberia, I / Chaloupka, P / Chang, Z / Chankova-Bunzarova, N / Chatterjee, A / Chattopadhyay, S / Chen, X / Chen, J H / Cheng, J / Cherney, M / Christie, W / Contin, G / Crawford, H J / Das, S / De Silva, L C / Dedovich, T G / Deng, J / Derevschikov, A A / Didenko, L / Dilks, C / Dong, X / Drachenberg, J L / Draper, J E / Dunkelberger, L E / Dunlop, J C / Efimov, L G / Elsey, N / Engelage, J / Eppley, G / Esha, R / Esumi, S / Evdokimov, O / Ewigleben, J / Eyser, O / Fatemi, R / Fazio, S / Federic, P / Federicova, P / Fedorisin, J / Feng, Z / Filip, P / Finch, E / Fisyak, Y / Flores, C E / Fujita, J / Fulek, L / Gagliardi, C A / Garand, D / Geurts, F / Gibson, A / Girard, M / Grosnick, D / Gunarathne, D S / Guo, Y / Gupta, A / Gupta, S / Guryn, W / Hamad, A I / Hamed, A / Harlenderova, A / Harris, J W / He, L / Heppelmann, S / Hirsch, A / Horvat, S / Huang, X / Huang, B / Huang, T / Huang, H Z / Humanic, T J / Huo, P / Igo, G / Jacobs, W W / Jentsch, A / Jia, J / Jiang, K / Jowzaee, S / Judd, E G / Kabana, S / Kalinkin, D / Kang, K / Kapukchyan, D / Kauder, K / Ke, H W / Keane, D / Kechechyan, A / Khan, Z / Kikoła, D P / Kim, C / Kisel, I / Kisiel, A / Kochenda, L / Kocmanek, M / Kollegger, T / Kosarzewski, L K / Kraishan, A F / Krauth, L / Kravtsov, P / Krueger, K / Kulathunga, N / Kumar, L / Kvapil, J / Kwasizur, J H / Lacey, R / Landgraf, J M / Landry, K D / Lauret, J / Lebedev, A / Lednicky, R / Lee, J H / Li, C / Li, X / Li, Y / Li, W / Lidrych, J / Lin, T / Lisa, M A / Liu, P / Liu, H / Liu, Y / Liu, F / Ljubicic, T / Llope, W J / Lomnitz, M / Longacre, R S / Luo, S / Luo, X / Ma, Y G / Ma, L / Ma, R / Ma, G L / Magdy, N / Majka, R / Mallick, D / Margetis, S / Markert, C / Matis, H S / Meehan, K / Mei, J C / Miller, Z W / Minaev, N G / Mioduszewski, S / Mishra, D / Mizuno, S / Mohanty, B / Mondal, M M / Morozov, D A / Mustafa, M K / Nasim, Md / Nayak, T K / Nelson, J M / Nie, M / Nigmatkulov, G / Niida, T / Nogach, L V / Nonaka, T / Nurushev, S B / Odyniec, G / Ogawa, A / Oh, K / Okorokov, V A / Olvitt, D / Page, B S / Pak, R / Pandit, Y / Panebratsev, Y / Pawlik, B / Pei, H / Perkins, C / Pile, P / Pluta, J / Poniatowska, K / Porter, J / Posik, M / Pruthi, N K / Przybycien, M / Putschke, J / Qiu, H / Quintero, A / Ramachandran, S / Ray, R L / Reed, R / Rehbein, M J / Ritter, H G / Roberts, J B / Rogachevskiy, O V / Romero, J L / Roth, J D / Ruan, L / Rusnak, J / Rusnakova, O / Sahoo, N R / Sahu, P K / Salur, S / Sandweiss, J / Saur, M / Schambach, J / Schmah, A M / Schmidke, W B / Schmitz, N / Schweid, B R / Seger, J / Sergeeva, M / Seto, R / Seyboth, P / Shah, N / Shahaliev, E / Shanmuganathan, P V / Shao, M / Sharma, A / Sharma, M K / Shen, W Q / Shi, S S / Shi, Z / Shou, Q Y / Sichtermann, E P / Sikora, R / Simko, M / Singha, S / Skoby, M J / Smirnov, N / Smirnov, D / Solyst, W / Song, L / Sorensen, P / Spinka, H M / Srivastava, B / Stanislaus, T D S / Strikhanov, M / Stringfellow, B / Suaide, A A P / Sugiura, T / Sumbera, M / Summa, B / Sun, Y / Sun, X M / Sun, X / Surrow, B / Svirida, D N / Tang, Z / Tang, A H / Taranenko, A / Tarnowsky, T / Tawfik, A / Thäder, J / Thomas, J H / Timmins, A R / Tlusty, D / Todoroki, T / Tokarev, M / Trentalange, S / Tribble, R E / Tribedy, P / Tripathy, S K / Trzeciak, B A / Tsai, O D / Ullrich, T / Underwood, D G / Upsal, I / Van Buren, G / van Nieuwenhuizen, G / Vasiliev, A N / Videbæk, F / Vokal, S / Voloshin, S A / Vossen, A / Wang, G / Wang, Y / Wang, F / Webb, J C / Webb, G / Wen, L / Westfall, G D / Wieman, H / Wissink, S W / Witt, R / Wu, Y / Xiao, Z G / Xie, G / Xie, W / Xu, J / Xu, Z / Xu, Q H / Xu, Y F / Xu, N / Yang, S / Yang, Y / Yang, C / Yang, Q / Ye, Z / Yi, L / Yip, K / Yoo, I-K / Yu, N / Zbroszczyk, H / Zha, W / Zhang, Z / Zhang, J B / Zhang, J / Zhang, S / Zhang, Y / Zhang, X P / Zhao, J / Zhong, C / Zhou, C / Zhou, L / Zhu, X / Zhu, Z / Zyzak, M

    Physical review letters

    2018  Volume 120, Issue 6, Page(s) 62301

    Abstract: Rapidity-odd directed-flow measurements at midrapidity are presented for Λ, Λ[over ¯], K^{±}, K_{s ...

    Abstract Rapidity-odd directed-flow measurements at midrapidity are presented for Λ, Λ[over ¯], K^{±}, K_{s}^{0}, and ϕ at sqrt[s_{NN}]=7.7, 11.5, 14.5, 19.6, 27, 39, 62.4, and 200 GeV in Au+Au collisions recorded by the Solenoidal Tracker detector at the Relativistic Heavy Ion Collider. These measurements greatly expand the scope of data available to constrain models with differing prescriptions for the equation of state of quantum chromodynamics. Results show good sensitivity for testing a picture where flow is assumed to be imposed before hadron formation and the observed particles are assumed to form via coalescence of constituent quarks. The pattern of departure from a coalescence-inspired sum rule can be a valuable new tool for probing the collision dynamics.
    Language English
    Publishing date 2018-02-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 208853-8
    ISSN 1079-7114 ; 0031-9007
    ISSN (online) 1079-7114
    ISSN 0031-9007
    DOI 10.1103/PhysRevLett.120.062301
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Non vitamin K oral anticoagulants versus antiplatelets in embolic stroke of undetermined source: most updated evidence.

    Chatterjee, Subhankar / Dubey, Souvik / Lahiri, Durjoy / Ray, Biman K

    Minerva cardioangiologica

    2019  Volume 67, Issue 4, Page(s) 340–347

    Abstract: Recent trial data have expanded the horizons of newer indications of non-vitamin K oral ...

    Abstract Recent trial data have expanded the horizons of newer indications of non-vitamin K oral anticoagulants (NOAC). Most recently they are being evaluated for use in embolic stroke of undetermined source (ESUS). ESUS are particularly known for their recurrences. So, identifying the causes and treating those etiological factors are the keys to secondary prevention of ESUS. Although traditional experts still opine for the use of antiplatelets for secondary prevention of ESUS as for other causes of embolic stroke, there are still room for improvement in delivery of optimal treatment strategy. So, NOAC is being tried as an alternative to traditional atiplatelet therapy in head-to-head trials. Unfortunately, recent trial data (from NAVIGATE-ESUS and RESPECT-ESUS) have not shown any added benefits (with comparable bleeding risk) of NOAC compared to aspirin in prevention of ESUS. This review intends to highlight the concept of ESUS, its varied etiologies, discuss the published and ongoing trials and tries to dig the reasons why the overall trial data have been disappointing. It also discusses the arenas where NOAC may be proved to be better than antiplatelets. Overall, we have stressed on the personalized case-to-case basis decision making while choosing the appropriate therapy in secondary prevention of ESUS.
    MeSH term(s) Administration, Oral ; Anticoagulants/administration & dosage ; Anticoagulants/pharmacology ; Aspirin/administration & dosage ; Humans ; Intracranial Embolism/prevention & control ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/pharmacology ; Secondary Prevention/methods ; Stroke/prevention & control
    Chemical Substances Anticoagulants ; Platelet Aggregation Inhibitors ; Aspirin (R16CO5Y76E)
    Language English
    Publishing date 2019-06-20
    Publishing country Italy
    Document type Comparative Study ; Journal Article ; Review
    ZDB-ID 123583-7
    ISSN 1827-1618 ; 0026-4725
    ISSN (online) 1827-1618
    ISSN 0026-4725
    DOI 10.23736/S0026-4725.19.04967-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Search for the rare decays K(L)→π0π0μ+μ- and K(L)→π0π0X0→π0π0μ+μ-.

    Abouzaid, E / Arenton, M / Barker, A R / Bellantoni, L / Blucher, E / Bock, G J / Cheu, E / Coleman, R / Corcoran, M D / Cox, B / Erwin, A R / Escobar, C O / Glazov, A / Golossanov, A / Gomes, R A / Gouffon, P / Hsiung, Y B / Jensen, D A / Kessler, R /
    Kotera, K / Ledovskoy, A / McBride, P L / Monnier, E / Nguyen, H / Niclasen, R / Phillips, D G / Ping, H / Ramberg, E J / Ray, R E / Ronquest, M / Santos, E / Slater, W / Smith, D / Solomey, N / Swallow, E C / Toale, P A / Tschirhart, R / Velissaris, C / Wah, Y W / Wang, J / White, H B / Whitmore, J / Wilking, M J / Winston, R / Worcester, E T / Worcester, M / Yamanaka, T / Zimmerman, E D / Zukanovich, R F

    Physical review letters

    2011  Volume 107, Issue 20, Page(s) 201803

    Abstract: The KTeV E799 experiment has conducted a search for the rare decays, K(L)→π(0)π(0)μ(+)μ(-) and K(L ... upper limits of Br(K(L)→π(0)π(0)X(0)→π(0)π(0)μ(+)μ(-)) < 1.0 × 10(-10) and Br(K(L)→π(0)π(0)μ(+)μ(-)) < 9 ...

    Abstract The KTeV E799 experiment has conducted a search for the rare decays, K(L)→π(0)π(0)μ(+)μ(-) and K(L)→π(0)π(0)X(0)→π(0)π(0)μ(+)μ(-), where the X(0) is a possible new neutral boson that was reported by the HyperCP experiment with a mass of (214.3 ± 0.5) MeV/c(2). We find no evidence for either decay. We obtain upper limits of Br(K(L)→π(0)π(0)X(0)→π(0)π(0)μ(+)μ(-)) < 1.0 × 10(-10) and Br(K(L)→π(0)π(0)μ(+)μ(-)) < 9.2 × 10(-11) at the 90% confidence level. This result rules out the pseudoscalar X(0) as an explanation of the HyperCP result under the scenario that the dsX(0) coupling is completely real.
    Language English
    Publishing date 2011-11-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 208853-8
    ISSN 1079-7114 ; 0031-9007
    ISSN (online) 1079-7114
    ISSN 0031-9007
    DOI 10.1103/PhysRevLett.107.201803
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Intercalated cell BKα subunit is required for flow-induced K+ secretion.

    Carrisoza-Gaytan, Rolando / Ray, Evan C / Flores, Daniel / Marciszyn, Allison L / Wu, Peng / Liu, Leah / Subramanya, Arohan R / Wang, WenHui / Sheng, Shaohu / Nkashama, Lubika J / Chen, Jingxin / Jackson, Edwin K / Mutchler, Stephanie M / Heja, Szilvia / Kohan, Donald E / Satlin, Lisa M / Kleyman, Thomas R

    JCI insight

    2020  Volume 5, Issue 8

    Abstract: ... collecting duct (CCD) of the mammalian kidney and have been proposed to be responsible for flow-induced K+ ... secretion (FIKS) and K+ adaptation. To examine the IC-specific role of BK channels, we generated a mouse ... sensitive (ChTX-sensitive) K+ currents were readily detected in control ICs but largely absent in ICs of IC ...

    Abstract BK channels are expressed in intercalated cells (ICs) and principal cells (PCs) in the cortical collecting duct (CCD) of the mammalian kidney and have been proposed to be responsible for flow-induced K+ secretion (FIKS) and K+ adaptation. To examine the IC-specific role of BK channels, we generated a mouse with targeted disruption of the pore-forming BK α subunit (BKα) in ICs (IC-BKα-KO). Whole cell charybdotoxin-sensitive (ChTX-sensitive) K+ currents were readily detected in control ICs but largely absent in ICs of IC-BKα-KO mice. When placed on a high K+ (HK) diet for 13 days, blood [K+] was significantly greater in IC-BKα-KO mice versus controls in males only, although urinary K+ excretion rates following isotonic volume expansion were similar in males and females. FIKS was present in microperfused CCDs isolated from controls but was absent in IC-BKα-KO CCDs of both sexes. Also, flow-stimulated epithelial Na+ channel-mediated (ENaC-mediated) Na+ absorption was greater in CCDs from female IC-BKα-KO mice than in CCDs from males. Our results confirm a critical role of IC BK channels in FIKS. Sex contributes to the capacity for adaptation to a HK diet in IC-BKα-KO mice.
    MeSH term(s) Animals ; Cell Line ; Charybdotoxin/pharmacology ; Ion Transport/drug effects ; Ion Transport/genetics ; Kidney Tubules, Collecting/metabolism ; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/antagonists & inhibitors ; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/genetics ; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/metabolism ; Mice ; Mice, Knockout ; Potassium/metabolism
    Chemical Substances BKCa protein, mouse ; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits ; Charybdotoxin (115422-61-2) ; Potassium (RWP5GA015D)
    Language English
    Publishing date 2020-04-07
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 2379-3708
    ISSN (online) 2379-3708
    DOI 10.1172/jci.insight.130553
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top